All posts
14550 total · page 38 of 291
India Produces 30% of Global Generic Medicines, Says Health Minister
India's contribution to the global generic drug market stands at 30%, according to MoS Health Anupriya Patel.
Night Shifts Linked to Metabolic Syndrome: A Medical Blind Spot
Doctors face increased health risks from night shifts, but the issue remains overlooked in healthcare.
Transparency in Medicine: Building Trust with Patients
The call for transparency in medicine grows as experts argue it strengthens patient trust.
Nepal Attracts Foreign Medical Students, While Nepalis Head Overseas
Nepal draws international medical students, yet twice as many Nepalis study medicine abroad.
Molbio Diagnostics IPO: A High-Risk Opportunity for Investors
Molbio Diagnostics plans a ₹200 crore IPO to boost capital expenditure, offering high-risk investors a potential growth opportunity.
Ebola Cases Surge Amid Improved Tracing Efforts in DR Congo
While contact tracing in DR Congo shows progress, Ebola continues to spread rapidly, reaching new provinces.
Study Finds Coffee Consumption Linked to Leaner Body Composition
New research reveals coffee's impact on body composition and hormone levels varies by sex.
Majority of Children Face Vitamin D Deficiency, New Study Finds
A recent study reveals that a significant number of children are not receiving adequate levels of Vitamin D, posing potential health risks.
Hospital Closures Force Pregnant Women to Travel Further for Delivery
Expectant mothers face longer journeys as labor units shut down nationwide.
Industry Pushback: Medical Devices Not Pharma, Say Companies
India's medical device sector opposes a draft bill treating devices like drugs, fearing it will stifle innovation.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Growth?
Molbio Diagnostics aims to raise ₹940 crore via IPO, targeting high-risk investors with growth potential.
CDC Reports Tick Migration South, Increasing Lyme Disease Risk
New CDC data indicates a southern migration of ticks, raising Lyme disease concerns beyond the Northeast.
Surrogate Fights for Custody After Refusing Abortion in High-Profile Case
An Alaska surrogate who refused an abortion after discovering a heart defect in the unborn child is now seeking parental rights in Texas.
Medical Device Industry Challenges Draft Bill Over Pharma Classification
India's medical device sector opposes a draft bill treating devices like drugs, citing risks to innovation and investment.
Molbio Diagnostics Seeks Growth with ₹940 Crore IPO
Molbio Diagnostics plans a ₹940 crore IPO, aiming to enhance capital and reduce promoter stake. The firm's growth hinges on its TB test kits.
Draft Bill Faces Pushback for Treating Medical Devices as Drugs
India's medical device sector opposes a draft bill equating devices with drugs, citing harm to innovation.
Molbio Diagnostics IPO Seeks ₹940 Crore for Growth Amid High-Risk Appeal
Molbio Diagnostics plans a ₹940 crore IPO to expand and reduce promoter stakes. Investors eyeing long-term growth should consider the risks.
Medical Device Industry Pushes Back on India's Draft Regulatory Bill
India's medical device sector opposes a draft bill likening devices to drugs, citing risks to innovation.
Asia-Pacific Leaders Call for Action on Health, Climate, AI
Asia-Pacific lawmakers urge stronger measures for health coverage, climate resilience, and responsible AI, says WHO.
Healthcare Costs Surge Ahead of Economic Growth
Healthcare spending growth outpaces the economy, raising concerns over sustainability.
GLP-1 Drugs: Transforming Healthcare and the Economy
The rise of GLP-1 drugs like Ozempic is reshaping healthcare and economic landscapes.
China's 5-Year Plan Urged to Prioritize Mental Health for Economic Growth
Experts call for integrating mental health strategies into China's economic plans, emphasizing its impact on productivity.
Molbio Diagnostics Eyes ₹200 Cr via IPO Amid Global Expansion
Molbio Diagnostics plans to raise ₹200 crore through an IPO, reducing promoter stake to 43%. Revenue surged 31.5% in recent years.
Finnish Study Suggests Coffee Boosts Metabolism Health
Research from Finland indicates regular coffee intake may enhance metabolic health.
New Animal Transmission Sparks Ebola Outbreak Concerns
A new Ebola outbreak, linked to animal transmission, has emerged in the Democratic Republic of Congo, raising global health concerns.
Southern U.S. Faces New Threat as Lyme-Carrying Ticks Expand Territory
Ticks carrying Lyme disease have been detected in the Southern U.S., raising concerns about local medical preparedness.
Medical Device Industry Challenges Draft Bill's Pharma Approach
India's medical device sector opposes a draft bill that equates devices with drugs, fearing stifled innovation and investment.
Molbio Diagnostics Aims for ₹200 Crore IPO to Boost Growth
Molbio Diagnostics plans a ₹200 crore IPO to expand its capital expenditures and decrease promoter stake, aiming for long-term growth prospects.
Indian Medical Device Industry Rejects Draft Bill Equating Devices with Drugs
India's medical device sector opposes a draft bill treating devices like drugs, citing potential harm to innovation and investment.
Molbio Diagnostics Aims for ₹940 Crore Through IPO for Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO, targeting ₹200 crore for expansion and reducing promoter stake.
Study Confirms No Link Between Covid Vaccines and Miscarriage
Despite recent claims, extensive data confirms Covid vaccines are safe and not linked to miscarriage.
Belém's Battle: Reducing Dengue Through Community Efforts
Belém, Brazil's proactive measures against a dengue outbreak offer insights for U.S. cities.
5-Year-Old Maddie Fries Stabilizes After 14-Month Chemotherapy Journey
Diagnosed with neurofibromatosis type 1, Maddie Fries, 5, completes 14 months of chemotherapy for two brain tumors, now stabilized.
American Teen's Death Linked to GLP-1 Weight Loss Drug
A 19-year-old student died from a fatal irregular heartbeat after taking a GLP-1 drug, highlighting potential risks.
Medical Device Industry Opposes India's 2026 Draft Bill
Medical device firms argue the 2026 draft bill equates devices with drugs, risking innovation.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Growth and Expansion
Molbio Diagnostics seeks ₹940 crore through IPO to fund expansion and reduce promoter stake. The firm targets growth in its diagnostics solutions.
Medical Device Industry Opposes Draft Bill Treating Devices as Drugs
India's medical device sector urges government to reconsider draft bill equating devices with drugs, citing potential harm to innovation and investment.
Max Healthcare Reports ₹2982 Cr Revenue, Profit Rises 3% in Q1 FY27
Max Healthcare's Q1 FY27 revenue surged 16% to ₹2,982 crore, with a 3% rise in profit to ₹357 crore, driven by expansions and strategic acquisitions.
Cardiologist Urges Transparency on Trump's Health in Editorial
A cardiologist's editorial calls for more transparency regarding former President Trump's health, citing a lack of public information.
Cheney's Cardiologist Raises Concerns Over Trump's Health
Dr. Jonathan Reiner, former cardiologist to Dick Cheney, questions the transparency of Trump's health disclosures.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fund Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund capital expenditures and reduce promoter stake, eyeing growth in global diagnostics market.
Study Highlights Persistent Sleep Quality Issues Post-Pandemic
Research identifies enduring factors affecting sleep quality, extending beyond COVID-19 impacts.
AI-Powered Triage Revolutionizes Acute Stroke Treatment
AI technology is transforming acute stroke triage, promising faster and more accurate patient assessment.
Tasmania Confirms First H5N1 Bird Flu Case Amid Australia's Growing Outbreak
Tasmania has reported its first H5N1 bird flu case, expanding Australia's outbreak footprint.
Medical Device Industry Pushes Back Against India's Draft Bill
India's medical device sector criticizes a draft bill that equates devices with pharmaceuticals, citing potential harm to innovation and investment.
Narayana Health Partners with NDB for Global Healthcare Innovation
Narayana Health and NDB collaborate to enhance healthcare through digital and data-driven solutions.
Molbio Diagnostics Seeks ₹940 Crore in IPO to Fuel Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO, reducing promoter stake and boosting global operations.
Effective Home Remedies for Common Aches and Pains
Discover practical tips on choosing the right medication for common aches and pains with guidance from Dr. Akshay Syal.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.
Molbio Diagnostics Targets ₹940 Crore Through IPO for Expansion
Molbio Diagnostics plans IPO to raise ₹940 crore for expansion and promoter stake reduction, appealing to high-risk investors.